Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma).
Matucci-Cerinic M, Giacomelli R, Pignone A, Cagnoni ML, Generini S, Casale R, Cipriani P, Del Rosso A, Tirassa P, Konttinen YT, Kahaleh BM, Fan PS, Paoletti M, Marchesi C, Cagnoni M, Aloe L. Matucci-Cerinic M, et al. Among authors: giacomelli r. Ann Rheum Dis. 2001 May;60(5):487-94. doi: 10.1136/ard.60.5.487. Ann Rheum Dis. 2001. PMID: 11302871 Free PMC article.
European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres.
Della Rossa A, Valentini G, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, Cerinic MM, Belch JF, Black CM, Becvar R, Bruhlman P, Cozzi F, Czirják L, Drosos AA, Dziankowska B, Ferri C, Gabrielli A, Giacomelli R, Hayem G, Inanc M, McHugh NJ, Nielsen H, Scorza R, Tirri E, van den Hoogen FH, Vlachoyiannopoulos PG. Della Rossa A, et al. Among authors: giacomelli r. Ann Rheum Dis. 2001 Jun;60(6):585-91. doi: 10.1136/ard.60.6.585. Ann Rheum Dis. 2001. PMID: 11350847 Free PMC article.
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes.
Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, Cerinic MM, Belch JF, Black CM, Bruhlmann P, Czirják L, De Luca A, Drosos AA, Ferri C, Gabrielli A, Giacomelli R, Hayem G, Inanc M, McHugh NJ, Nielsen H, Rosada M, Scorza R, Stork J, Sysa A, van den Hoogen FH, Vlachoyiannopoulos PJ. Valentini G, et al. Among authors: giacomelli r. Ann Rheum Dis. 2001 Jun;60(6):592-8. doi: 10.1136/ard.60.6.592. Ann Rheum Dis. 2001. PMID: 11350848 Free PMC article.
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations.
Generini S, Giacomelli R, Fedi R, Fulminis A, Pignone A, Frieri G, Del Rosso A, Viscido A, Galletti B, Fazzi M, Tonelli F, Matucci-Cerinic M. Generini S, et al. Among authors: giacomelli r. Ann Rheum Dis. 2004 Dec;63(12):1664-9. doi: 10.1136/ard.2003.012450. Epub 2004 Aug 5. Ann Rheum Dis. 2004. PMID: 15297279 Free PMC article. Clinical Trial.
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes.
Del Rosso A, Cinelli M, Guiducci S, Pignone A, Fibbi G, Margheri F, Gabrielli A, Giacomelli R, Coppini A, Del Rosso M, Matucci Cerinic M. Del Rosso A, et al. Among authors: giacomelli r. Rheumatology (Oxford). 2005 Oct;44(10):1255-62. doi: 10.1093/rheumatology/kei006. Epub 2005 Jul 5. Rheumatology (Oxford). 2005. PMID: 15998634
410 results